PARP drugs for Breast Cancer

2 tracked PARP drugs in the Breast Cancer race. The class explanation lives on the PARP page; the full indication pipeline across every mechanism is on the Breast Cancer page.

2 approved / phase 4

Head-to-head evidence: Olaparib vs Talazoparib

The roster

← all PARP drugs